Ingestible Compositions Comprising Antibacterial Agents

David Blake; Cliff Stevens; Robert Eisenthal; R Harrison; Timothy Mark  Millar; Edwards  Rachel

Ingestible Compositions Comprising Antibacterial Agents

David Blake (Inventor), Cliff Stevens (Inventor), Robert Eisenthal (Inventor), R Harrison (Inventor), Timothy Mark Millar (Inventor), Edwards Rachel (Inventor)

Research output: Patent

Abstract

A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a "natural antibiotic" to prevent or reduce bacterial infection within the gut, especially the neonatal gut.

Original language	English
Patent number	WO0011965 (A2)
IPC	A23C9/12
Publication status	Published - 9 Mar 2000

Cite this

@misc{0adfa6d1dc404f4ca2eae65d1752749f,

title = "Ingestible Compositions Comprising Antibacterial Agents",

abstract = "A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a {"}natural antibiotic{"} to prevent or reduce bacterial infection within the gut, especially the neonatal gut.",

author = "David Blake and Cliff Stevens and Robert Eisenthal and R Harrison and Millar, {Timothy Mark} and Edwards Rachel",

year = "2000",

month = mar,

day = "9",

language = "English",

type = "Patent",

note = "WO0011965 (A2); A23C9/12",

}

TY - PAT

T1 - Ingestible Compositions Comprising Antibacterial Agents

AU - Blake, David

AU - Stevens, Cliff

AU - Eisenthal, Robert

AU - Harrison, R

AU - Millar, Timothy Mark

AU - Rachel, Edwards

PY - 2000/3/9

Y1 - 2000/3/9

N2 - A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a "natural antibiotic" to prevent or reduce bacterial infection within the gut, especially the neonatal gut.

AB - A formulation for use as a bactericidal agent in the human or animal digestive system includes xanthine oxidoreductase. The formulation may especially be in the form of a formula feed formulation or enteral feed formulation for administration to a human or animal. The formulation is capable of functioning as a "natural antibiotic" to prevent or reduce bacterial infection within the gut, especially the neonatal gut.

M3 - Patent

M1 - WO0011965 (A2)

ER -

Ingestible Compositions Comprising Antibacterial Agents

Abstract

Fingerprint

Cite this